Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • 1995-1999  (1)
  • 1980-1984  (1)
  • Amino acids  (1)
  • Intradermal (i.d.) injection  (1)
  • 1
    Electronic Resource
    Electronic Resource
    Springer
    Archives of dermatological research 270 (1981), S. 413-419 
    ISSN: 1432-069X
    Keywords: Epidermal vacuolation ; Local anesthetics ; Intradermal (i.d.) injection ; Subcutaneous (s.c.) injection ; Epidermale Vacuolisierung ; Lokalanaestheticum ; intradermale (i.d.) Injektion ; subcutane (s.c.) Injektion
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Zusammenfassung Um den Mechanismus der Vacuolisierung zu erklären, die man häufig in den normalen Epidermiszellen in der Umgebung der Hauttumoren beobachtet, wurden 0.5 und 1.0% Procainhydrochlorid mit und ohne Epinephrine injiziert — entweder i.d. oder s.c. — und zwar bei reifen weißen männlichen Kaninchen. Die Injektionsstellen entweder sofort oder nach 15 min excidiert. Die Epidermis zeigte an der Stelle der i.d. Injektion eine signifikantere Zunahme der Zahl der vacuolisierteten Zellen als die der s.c. Injektionen (P〈0.001) ohne Rücksicht auf die Art der Lokalanaesthetica und die Zeitdauer zwischen Injektion und Excision. Die Elektronenmikroskopie stellte die intracytoplasmischen Vacuolen ohne abgrenzende Membran im Cytoplasma der Keratinocyten dar. Das im oberem Corium lokalisierte Ödem infolge der Injektion des Betäubungsmittels verursacht das Ödem und die Vacuolisierung in den bedeckenden Epidermiszellen. Die i.d. Injektion des Lokalanaestheticums möchten wir als eine Ursache der epidermalen Vacuolisierung auffassen.
    Notes: Summary To elucidate the mechanism of vacuolation frequently encountered in the normal epidermal cells surrounding skin tumors, 0.5 and 1.0% procaine hydrochloride, and 1.0% lidocaine hydrochloride with and without epinephrine were injected either i.d. or s.c. into mature white male rabbits, and the sites of injection were biopsied either immediately or after 15 min. The epidermis of the site of intradermal injection showed a significant increase in the number of vacuolated cells in contrast to the site of s.c. injection (P〈0.001) irrespective of the kinds of local anesthetics and the time lapse from injection to biopsy. Electron microscopy revealed vacuole-formations without limiting membrane in the cytoplasm of the kerationocytes. It is suggested that the local edema in the upper dermis caused by injection of anesthetics gives rise to edema and vacuolation of overlying epidermal cells, and that i.d. injection of local anesthetics may be regarded as a cause of epidermal vacuolation.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    ISSN: 1438-2199
    Keywords: Amino acids ; Imidazole compound ; Mercaptopyruvic acid ; Urocanic acid ; Histidine ; Mass spectrometry ; Paper electrophoresis
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary S-[2-Carboxy-1-(1H-imidazol-4-yl)ethyl]-3-mercaptopyruvic acid (I) was chemically synthesized in 15% yield by incubating a reaction mixture oftrans-urocanic acid and 3-fold excess of 3-mercaptopyruvic acid at 45°C for 6 days. The synthesized compound was characterized by fast-atom-bombardment mass spectrometry and high-voltage paper electrophoresis. CompoundI was identified with a product of an enzymatic reaction ofS-[2-carboxy-1-(1H-imidazol-4-yl)ethyl]-l-cysteine (II) with rat liver homogenate in a phosphate buffer, pH 7.4. CompoundI was degraded toS-[2-carboxy-1-(1H-imidazol-4-yl)ethyl]-3-mercaptolactic acid (III), a compound previously found in human urine [Kinuta et al. (1994) Biochem J 297: 475–478], by incubation with rat liver homogenate. From these results, we suggest that compoundI is a metabolic intermediate for the formation of compoundIII from compoundII. The present pathway follows a formation of compoundII fromS-[2-carboxy-1-(1H-imidazol-4-yl)ethyl] gluthathione [Kinuta et al. (1993) Biochim Biophys Acta 1157: 192–198], a proposed metabolite ofl-histidine.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...